Considering the role of four months of rifampin in the treatment of latent tuberculosis infection

MeSH terms

• Animals
• Antibiotics, Antitubercular / administration & dosage
• Antibiotics, Antitubercular / economics
• Antibiotics, Antitubercular / therapeutic use*
• Antitubercular Agents / adverse effects
• Antitubercular Agents / therapeutic use
• Chemical and Drug Induced Liver Injury / etiology
• Costs and Cost Analysis
• Drug Administration Schedule
• Drug Resistance, Bacterial
• Drug Therapy, Combination
• Emigration and Immigration
• Humans
• Isoniazid / adverse effects
• Isoniazid / therapeutic use
• Mice
• Mycobacterium tuberculosis / drug effects
• Patient Compliance
• Rifampin / administration & dosage
• Rifampin / economics
• Rifampin / therapeutic use*
• Time Factors
• Tuberculosis / drug therapy*
• United States